摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N.N'-Dicyclohexyl-O-(2-trimethylsilyl-aethyl)-isoharnstoff | 65057-62-7

中文名称
——
中文别名
——
英文名称
N.N'-Dicyclohexyl-O-(2-trimethylsilyl-aethyl)-isoharnstoff
英文别名
2-trimethylsilylethyl N,N'-dicyclohexylcarbamimidate
N.N'-Dicyclohexyl-O-(2-trimethylsilyl-aethyl)-isoharnstoff化学式
CAS
65057-62-7
化学式
C18H36N2OSi
mdl
——
分子量
324.582
InChiKey
LKIJLCVIHKRAIA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    451.6±24.0 °C(Predicted)
  • 密度:
    1.02±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.95
  • 重原子数:
    22
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    33.6
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    N.N'-Dicyclohexyl-O-(2-trimethylsilyl-aethyl)-isoharnstoff盐酸 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 24.0h, 生成 (2R)-2,3-dihydroxypropanoic acid β-trimethylsilylethyl ester
    参考文献:
    名称:
    Solution-Phase and Solid-Phase Syntheses of Enzyme Inhibitor RK-682 and Antibiotic Agglomerins
    摘要:
    The enzyme inhibitor RK-682 (5R)-(+)-1 was prepared in solution and on a solid support from (2R)-glycerates in five steps and ca. 40% overall yield. Key steps were a ring-closing tandem addition-Wittig alkenation reaction of the respective protected or immobilized glycerates with the ylide Ph-3-PCCO and the 3-acylation of the tetronic acids thus obtained with palmitic acid. A similar route extended by a mesylation-elimination sequence led to antibiotic agglomerins A-C 2 featuring 3-acyl-5-methylidenetetronic acid structures.
    DOI:
    10.1021/jo050797i
点击查看最新优质反应信息

文献信息

  • 2-Pyridyl-2-thiazoline-4-carboxylic acid derivatives
    申请人:Ciba-Geigy Corporation
    公开号:US04406905A1
    公开(公告)日:1983-09-27
    The invention relates especially to 2-(3'-hydroxypyrid-2'-yl)-2-thiazoline-4-carboxylic acid derivatives of the formula (I) and salts and also certain metal complexes of these compounds, processes for their manufacture, pharmaceutical agents containing such compounds and the use of these compounds. ##STR1## In the formula, R.sup.1 represents free, etherified or esterified hydroxy, R.sup.2 represents hydrogen or an aliphatic, carbocyclic or carbocyclic-aliphatic radical having 1-12 carbon atoms, and R.sup.3 represents hydrogen or an unsubstituted aliphatic radical having 1-7 carbon atoms. The compounds of the formula (I) can be used, for example, for the abstraction of heavy metals from the organism of warm-blooded animals and/or they have an antibiotic action.
    本发明特别涉及公式(I)的2-(3'-羟基吡啶-2'-基)-2-噻唑啉-4-羧酸衍生物及其盐,以及这些化合物的某些金属配合物,制造这些化合物的过程,含有这些化合物的药物制剂和这些化合物的用途。 在公式中,R1代表自由、醚化或酯化的羟基,R2代表氢或具有1-12个碳原子的脂肪、环烷或环烷基脂肪基,R3代表氢或具有1-7个碳原子的未取代脂肪基。公式(I)的化合物可以用于从温血动物的有机体中提取重金属,或具有抗生素作用。
  • Solution-Phase and Solid-Phase Syntheses of Enzyme Inhibitor RK-682 and Antibiotic Agglomerins
    作者:Rainer Schobert、Carsten Jagusch
    DOI:10.1021/jo050797i
    日期:2005.7.1
    The enzyme inhibitor RK-682 (5R)-(+)-1 was prepared in solution and on a solid support from (2R)-glycerates in five steps and ca. 40% overall yield. Key steps were a ring-closing tandem addition-Wittig alkenation reaction of the respective protected or immobilized glycerates with the ylide Ph-3-PCCO and the 3-acylation of the tetronic acids thus obtained with palmitic acid. A similar route extended by a mesylation-elimination sequence led to antibiotic agglomerins A-C 2 featuring 3-acyl-5-methylidenetetronic acid structures.
查看更多